Project Violet team member Dr. Drew Mhyre and what research means to him and his family
As told to Susan Keown
In 2013, pharmacologist Dr. Andrew (Drew) Mhyre joined Fred Hutch’s Project Violet to lead the therapeutics discovery group, supported in part by Innovators Network. His team is focused on identifying small- and medium-sized molecules that have drug-like characteristics and then matching them with the most promising therapeutic targets to treat pediatric cancers and other rare diseases. For Drew, the search for new treatments of rare diseases is not just a matter of professional interest ― it’s personal.